
Warren Buffett, one of the wealthiest people alive and renowned investor, has given his own insight into Microsoft’s acquisition of Activision Blizzard, stating that he believes the deal will go through.
Earlier this year, much to the shock of everyone, Microsoft announced it was planning to acquire Activision Blizzard for just shy of $70 billion. If it goes through, it will be the biggest deal in the history of the gaming industry and give Microsoft ownership of massive franchises like Call of Duty, World of Warcraft, Overwatch, and many, many more.
Due to the immensity of the deal, there has been some pushback from politicians and investors, leading some to believe the deal could get shot down.
Warren Buffett, however, has bet that deal will be approved. The billionaire investor’s company, Berkshire Hathaway, increased its position in the company from 2% to 9.5%, a position worth about $6 billion. Buffett made it clear that it was his decision to increase the position.
“It is my purchase, not the manager who bought it some months ago,” said Buffett. “If the deal goes through, we make some money.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas